Kwee Yong

46PUBLICATIONS
154CO-AUTHORS
Innate immunityPredictive and prognostic markersHaematological tumoursGene and molecular therapyChiropractic
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Apr 30, 2026
Immune clues to infection risk in myeloma.

|Mar 25, 2026
Enhanced dynamic risk stratification of smoldering multiple myeloma.

Floris Chabrun, Daniel E Schwartz, Susanna Gentile

|Feb 05, 2026
Tumour-intrinsic features shape T cell differentiation through precursor to symptomatic multiple myeloma.

Kane A Foster, Elise Rees, Louise Ainley

|Jun 12, 2025
Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0).

Floris Chabrun, Daniel Schwartz, Susanna Gentile

|Apr 02, 2025
Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group Study.

Carlyn Rose Tan, Sireesha Asoori, Chiung-Yu Huang

|Mar 21, 2025
Outcomes of frailty subgroups of older adults (age ≥ 70) treated with teclistamab: an International Myeloma Foundation immunotherapy database real-world analysis.

Hira Mian, Thomas G Martin, Gregory R Pond

Pageof 8

Frequent Collaborators

11 joint publications

Rakesh Popat

8 joint publications

Selina J Chavda

7 joint publications

Meletios-Athanasios Dimopoulos

5 joint publications

Louise Ainley